Evidence map›Paper›PMID 23071255›Full record

ArticleThe Journal of experimental medicine2012

Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen.

Justin J Taylor, Ryan J Martinez, Philip J Titcombe, Laura O Barsness, Stephanie R Thomas, Na Zhang, Shoshana D Katzman, Marc K Jenkins, Daniel L Mueller

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Distributed Clonal Deletion Prevents Autoimmune Disease Progression.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Blunting specific T-dependent antibody responses with engineered "decoy" B cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Justin J TaylorDepartment of Medicine and 2 Department of Microbiology, Center for Immunology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Ryan J Martinez
Philip J Titcombe
Laura O Barsness
Stephanie R Thomas
Na Zhang
Shoshana D Katzman
Marc K Jenkins
Daniel L Mueller

Funding

Type I interferons in tolerance in the steady stateP01AI035296 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI FIFE, BRIAN T · 1993 to 2023
$31.1M
TRAINING GRANT IN MICROBIOLOGY/CANCER RESEARCHT32CA009138 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Scott M. Dehm · 1985 to 2026
$11.3M
Costimulatory Signals in CD4+ T Cell ActivationR37AI027998 · NIAID · UNIVERSITY OF MINNESOTA · PI JENKINS, MARC KEVIN · 2008 to 2017
$3.7M
Epigenetic Control of T cell AutoimmunityR01AI080764 · NIAID · UNIVERSITY OF MINNESOTA · PI MUELLER, DANIEL L · 2009 to 2010
$755k
Investigating the functional development of memory B cellsF32AI091033 · NIAID · UNIVERSITY OF MINNESOTA · PI TAYLOR, JUSTIN J · 2010 to 2011
$73k
NCI NIH HHS T32 CA009138NIAID NIH HHS F32 AI091033NIAID NIH HHS P01 AI035296NIAID NIH HHS P01 AI35296NIAID NIH HHS R01 AI036914NIAID NIH HHS R01 AI080764NIAID NIH HHS R01 AI80764NIAID NIH HHS R37 AI027998NIAID NIH HHS R37AI027998
6 · The paper itself

Abstract

B cell tolerance to self-antigen is critical to preventing antibody-mediated autoimmunity. Previous work using B cell antigen receptor transgenic animals suggested that self-antigen-specific B cells are either deleted from the repertoire, enter a state of diminished function termed anergy, or are ignorant to the presence of self-antigen. These mechanisms have not been assessed in a normal polyclonal repertoire because of an inability to detect rare antigen-specific B cells. Using a novel detection and enrichment strategy to assess polyclonal self-antigen-specific B cells, we find no evidence of deletion or anergy of cells specific for antigen not bound to membrane, and tolerance to these types of antigens appears to be largely maintained by the absence of T cell help. In contrast, a combination of deleting cells expressing receptors with high affinity for antigen with anergy of the undeleted lower affinity cells maintains tolerance to ubiquitous membrane-bound self-antigens.

Indexed as

Adoptive TransferAnimalsArthritisAutoantigensB-LymphocytesCell MembraneClonal AnergyClonal DeletionClone CellsFemaleFlow CytometryGlycosylphosphatidylinositolsLymphocyte CountMaleMiceMice, 129 StrainAutoantigensGlycosylphosphatidylinositolsOvalbuminReceptors, Antigen, B-Cell

Identifiers

PMID23071255
PMCPMC3478923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.